MAPT and Alzheimer disease: In addition, other potential biomarkers for the early detection of AD pathology have been found, such as plasma proteins, lipids, Aβ-40, Aβ-42, and their ratio, tau, and beta-secretase 1 (BACE-1) [9,10].